Vion Pharmaceuticals, Inc. (Nasdaq: VION, news, msgs)
today announced the final results from the company's 2000 Annual Meeting of Stockholders, which was held
on October 23, 2000 at The Kitano Hotel located at 66 Park Avenue in New York City at 3:00 p.m. Eastern
Time.
The company's proxy statement asked each stockholder to vote on the following four proposals:
i) to elect eight directors to hold office until the next annual meeting
of stockholders or until their successors are elected and qualified;
ii) to approve the amendment to the company's certificate of incorporation
and to adopt the provisions related to a classified board of
directors;
iii) to approve the adoption of Vion Pharmaceuticals, Inc. 2000 Employee
Stock Purchase Plan; and
iv) to ratify the appointment of Ernst & Young LLP as the company's
independent auditors for the year ending December 31, 2000.
The outcome was as follows:
i) the stockholders elected William R. Miller, Alan Kessman,
Michael C. Bergerac, Frank T. Carey, James L. Ferguson,
Alan C. Sartorelli, Ph.D., Walter B. Wriston and Charles K. MacDonald
to the company's Board of Directors;
ii) proposal two was not approved;
iii) the stockholders approved the Employee Stock Purchase Plan; and
iv) the stockholders approved the appointment of Ernst & Young as
independent auditors.
A copy of the corporate slide presentation presented at the Annual Meeting
highlighting the affairs of the company can be found on the company's
website at vionpharm.com, effective November 7, 2000. |
